Entos Pharmaceuticals Inc.
ID: 7354277Entos Pharmaceuticals develops nucleic acid-based therapies using its proprietary Fusogenix drug delivery system.
3
Funding Rounds
$5.0m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| An***** Zi****** | - | - | linkedin twitter |
| Ro* Du**** | - | - | |
| Jo** D. Le*** |
|
- | linkedin twitter |
Funding
Funding series
Funding Series Analysis
The company Entos Pharmaceuticals Inc. has raised a total of $5m in funding over 3 rounds.
Key Insights:
- Entos Pharmaceuticals Inc. May 2025 Venture Round Funding Round: $1m
- Entos Pharmaceuticals Inc. June 2025 Venture Series Funding Round: $4m
Industries
Entos Pharmaceuticals Inc. is active in the following industries: